Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LNTH
|
Heinz Christoph Maeusli |
BUY
Open market or private purchase
|
Direct | 1,000 Added 6.57% |
$19,390
$19.39 p/Share
|
Feb 19
2021 |
|
AVXL
|
Peter D.O. Donhauser
Director |
BUY
Open market or private purchase
|
Direct | 1,165 Added 50.0% |
$14,912
$12.8 p/Share
|
Feb 19
2021 |
|
THW
|
Lucinda H Stebbins
Director |
BUY
Open market or private purchase
|
Direct | 750 Added 50.0% |
$12,600
$16.8 p/Share
|
Feb 19
2021 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 11,786 Added 0.25% |
$233,009
$19.77 p/Share
|
Feb 19
2021 |
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 11,786 Added 0.25% |
$233,009
$19.77 p/Share
|
Feb 19
2021 |
|
CBAN
|
Lee Bagwell
Executive VP |
BUY
Open market or private purchase
|
Indirect | 545 Added 4.27% |
$7,924
$14.54 p/Share
|
Feb 19
2021 |
|
APLT
|
Stacy J. Kanter |
BUY
Open market or private purchase
|
Direct | 6,500 Added 33.33% |
$148,590
$22.86 p/Share
|
Feb 19
2021 |
|
CBAN
|
Tracie Youngblood
Exec. Vice President & CFO |
BUY
Open market or private purchase
|
Indirect | 277 Added 50.0% |
$4,028
$14.54 p/Share
|
Feb 19
2021 |
|
CBAN
|
Kimberly C. Dockery
Chief of Staff, EVP |
BUY
Open market or private purchase
|
Indirect | 1,444 Added 21.34% |
$20,996
$14.54 p/Share
|
Feb 19
2021 |
|
CBAN
|
Leonard H Bateman Jr
EVP & Chief Credit Officer |
BUY
Open market or private purchase
|
Indirect | 763 Added 8.8% |
$11,094
$14.54 p/Share
|
Feb 19
2021 |
|
CBAN
|
M. Edward Hoyle Jr.
Chief Banking Officer, EVP |
BUY
Open market or private purchase
|
Indirect | 989 Added 7.31% |
$14,380
$14.54 p/Share
|
Feb 19
2021 |
|
MACAU
|
Moringa Sponsor, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 325,000 Added 50.0% |
$3,250,000
$10.0 p/Share
|
Feb 19
2021 |
|
VINO
|
Edie Rodriguez
Director |
BUY
Open market or private purchase
|
Direct | 8,333 Added 50.0% |
$49,998
$6.0 p/Share
|
Feb 19
2021 |
|
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,009 Added 0.32% |
$6,780
$6.72 p/Share
|
Feb 19
2021 |
|
WBHC
|
Lisa Pominski
EVP |
BUY
Open market or private purchase
|
Indirect | 500 Added 9.79% |
$29,375
$58.75 p/Share
|
Feb 19
2021 |
|
TJX
|
Zein Abdalla
Director |
BUY
Open market or private purchase
|
Indirect | 76 Added 0.36% |
$5,187
$68.25 p/Share
|
Feb 19
2021 |
|
VINO
|
Reuben Cannon
Director |
BUY
Open market or private purchase
|
Direct | 3,333 Added 50.0% |
$19,998
$6.0 p/Share
|
Feb 19
2021 |
|
TESS
|
Kathleen Mc Lean |
BUY
Open market or private purchase
|
Direct | 666 Added 31.84% |
$5,494
$8.25 p/Share
|
Feb 18
2021 |
|
SCPS
|
Ira Scott Greenspan
Executive Committee Chairman |
BUY
Open market or private purchase
|
Indirect | 2,200 Added 30.99% |
$22,088
$10.04 p/Share
|
Feb 18
2021 |
|
TWO
|
William Ross Greenberg
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 17,500 Added 8.42% |
$114,275
$6.53 p/Share
|
Feb 18
2021 |
|
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.84% |
$1,497
$9.98 p/Share
|
Feb 18
2021 |
|
NWBI
|
Mark T. Reitzes
SEVP, Commercial Banking |
BUY
Open market or private purchase
|
Indirect | 9,200 Added 28.98% |
$125,304
$13.62 p/Share
|
Feb 18
2021 |
|
CSTR
|
Christopher G Tietz
Chief Banking Officer |
BUY
Open market or private purchase
|
Indirect | 214 Added 13.87% |
-
|
Feb 18
2021 |
|
XAIR
|
Robert Carey
Director |
BUY
Open market or private purchase
|
Direct | 15,000 Added 11.59% |
$100,050
$6.67 p/Share
|
Feb 18
2021 |
|
RNDB
|
Louis J. Trubiano
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.83% |
$20,170
$20.17 p/Share
|
Feb 18
2021 |
|
HEPA
|
Robert T Foster
CEO and Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 30.65% |
$40,000
$2.0 p/Share
|
Feb 18
2021 |
|
HEPA
|
John T Cavan
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 40.32% |
$20,000
$2.0 p/Share
|
Feb 18
2021 |
|
ILAL
|
Jason Sunstein
Vice President and CFO |
BUY
Open market or private purchase
|
Direct | 54,437 Added 1.3% |
$65,324
$1.2 p/Share
|
Feb 18
2021 |
|
JANL
|
Gerard Van Kesteren
Director |
BUY
Open market or private purchase
|
Direct | 2,200 Added 5.01% |
$30,800
$14.0 p/Share
|
Feb 18
2021 |
|
MKL
|
A. Lynne Puckett
Director |
BUY
Open market or private purchase
|
Direct | 90 Added 26.16% |
$98,298
$1092.2 p/Share
|
Feb 18
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 45 Added 0.31% |
$49,942
$1109.83 p/Share
|
Feb 18
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 5 Added 0.41% |
$5,549
$1109.83 p/Share
|
Feb 18
2021 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.21% |
$1,552
$2.3 p/Share
|
Feb 18
2021 |
|
HSIC
|
Mohamad Ali |
BUY
Open market or private purchase
|
Direct | 1,000 Added 50.0% |
$63,650
$63.65 p/Share
|
Feb 18
2021 |
|
QUOT
|
Andrew J Gessow
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 7.21% |
$59,900
$11.98 p/Share
|
Feb 18
2021 |
|
NKSH
|
John Elliott Dooley
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 11.63% |
$33,000
$33.0 p/Share
|
Feb 18
2021 |
|
CZWI
|
Stephen M Bianchi
CEO and President |
BUY
Open market or private purchase
|
Indirect | 281 Added 0.71% |
$3,102
$11.04 p/Share
|
Feb 18
2021 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 753 Added 0.02% |
$14,872
$19.75 p/Share
|
Feb 18
2021 |
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 753 Added 0.02% |
$14,872
$19.75 p/Share
|
Feb 18
2021 |
|
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 1,185,770 Added 13.31% |
$14,999,990
$12.65 p/Share
|
Feb 18
2021 |
|
SPLP
|
Gordon A. Walker
Senior Vice President |
BUY
Open market or private purchase
|
Indirect | 2,596 Added 8.39% |
$53,504
$20.61 p/Share
|
Feb 18
2021 |
|
PRTA
|
Eco R1 Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 44,100 Added 0.43% |
$162,288
$3.68 p/Share
|
Feb 18
2021 |
|
CVX
|
Marillyn A Hewson
Director |
BUY
Open market or private purchase
|
Direct | 3,200 Added 42.89% |
$304,672
$95.21 p/Share
|
Feb 18
2021 |
|
WMS
|
Berkshire Partners Holdings LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1 Added 0.0% |
$97
$96.75 p/Share
|
Feb 18
2021 |
|
WMS
|
Ross M Jones
Director |
BUY
Open market or private purchase
|
Indirect | 1 Added 0.0% |
$97
$96.75 p/Share
|
Feb 18
2021 |
|
MLI
|
Scott Jay Goldman
Director |
BUY
Open market or private purchase
|
Direct | 400 Added 2.56% |
$14,828
$37.07 p/Share
|
Feb 18
2021 |
|
NUS
|
Daniel W Campbell
Director |
BUY
Open market or private purchase
|
Direct | 5,055 Added 5.56% |
$250,172
$49.49 p/Share
|
Feb 18
2021 |
|
NUS
|
Daniel W Campbell
Director |
BUY
Open market or private purchase
|
Indirect | 5,055 Added 33.55% |
$250,121
$49.48 p/Share
|
Feb 18
2021 |
|
AAT
|
Ernest S Rady
Chairman & CEO |
BUY
Open market or private purchase
|
Indirect | 58,379 Added 3.26% |
$1,718,678
$29.44 p/Share
|
Feb 18
2021 |
|
VVI
|
Andrew B Benett
Director |
BUY
Open market or private purchase
|
Direct | 1,340 Added 6.28% |
$50,799
$37.91 p/Share
|
Feb 18
2021 |